BioXcel Therapeutics, Inc. (BTAI) is a biopharmaceutical company using artificial intelligence to develop medicines in neuroscience and immuno-oncology. Its lead product, IGALMI (dexmedetomidine sublingual film), is FDA-approved for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Its pipeline includes BXCL501 for additional agitation indications and BXCL701, an oral innate immune activator for prostate cancer, pancreatic cancer, and other tumors, developed through subsidiary OnkosXcel Therapeutics.
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001104659-26-036214 | EDGAR | 145K words |
| 2025-03-28 | 2024-12-31 | 0001558370-25-003985 | EDGAR | 140K words |
| 2024-03-22 | 2023-12-31 | 0001558370-24-003784 | EDGAR | 117K words |
| 2023-03-16 | 2022-12-31 | 0001558370-23-003940 | EDGAR | 94K words |
| 2022-03-11 | 2021-12-31 | 0001558370-22-003335 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001558370-21-002916 | EDGAR | — |
| 2020-03-09 | 2019-12-31 | 0001558370-20-002196 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001558370-19-001798 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001104659-26-095965 | EDGAR | 94K words |
| 2025-11-12 | 2025-09-30 | 0001104659-25-109880 | EDGAR | 96K words |
| 2025-08-12 | 2025-06-30 | 0001558370-25-011158 | EDGAR | 94K words |
| 2025-05-12 | 2025-03-31 | 0001558370-25-007269 | EDGAR | 91K words |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015629 | EDGAR | 96K words |
| 2024-08-06 | 2024-06-30 | 0001558370-24-010967 | EDGAR | 95K words |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007481 | EDGAR | 91K words |
| 2023-11-14 | 2023-09-30 | 0001558370-23-018917 | EDGAR | 81K words |
| 2023-08-14 | 2023-06-30 | 0001558370-23-014729 | EDGAR | 77K words |
| 2023-05-09 | 2023-03-31 | 0001558370-23-008597 | EDGAR | 68K words |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017592 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013353 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-01 | 0001104659-26-104106 | EDGAR | 2K words |
| 2026-08-28 | 0001104659-26-102570 | EDGAR | 2K words |
| 2026-08-25 | 0001104659-26-100532 | EDGAR | 71K words |
| 2026-08-24 | 0001104659-26-099900 | EDGAR | 1K words |
| 2026-08-11 | 0001104659-26-093710 | EDGAR | 1K words |
| 2026-08-03 | 0001104659-26-089436 | EDGAR | 6K words |
| 2026-04-01 | 0001104659-26-038174 | EDGAR | 0K words |
| 2026-03-27 | 0001104659-26-035661 | EDGAR | 3K words |
| 2026-03-11 | 0001104659-26-026409 | EDGAR | 18K words |
| 2026-02-12 | 0001104659-26-013840 | EDGAR | 2K words |
242 total filings indexed. 212 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001720893 |
| Ticker | BTAI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.bioxceltherapeutics.com |
| Listed | 2018-03-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BTAI (~200 tokens, structured JSON with cryptographic provenance)